Retrospective Study
Copyright ©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Jul 28, 2014; 20(28): 9549-9555
Published online Jul 28, 2014. doi: 10.3748/wjg.v20.i28.9549
Esophageal dilations in eosinophilic esophagitis: A single center experience
Andrew Ukleja, Jennifer Shiroky, Amitesh Agarwal, Daniela Allende
Andrew Ukleja, Jennifer Shiroky, Department of Gastroenterology, Cleveland Clinic Florida, Weston, FL 33331, United States
Daniela Allende, Cleveland Clinic, OH 44195, United States
Amitesh Agarwal, the University of Texas Medical Branch at Galveston, Galveston, TX 77555, United States
Author contributions: Ukleja A and Agarwal A were the treating physicians; Allende D analyzed and assessed the slides; Ukleja A and Shiroky J researched the topic; Shiroky J, Allende D and Agarwal A collected the data; Shiroky J wrote the manuscript; Ukleja A, Shiroky J and Allende D revised and edited the manuscript.
Correspondence to: Andrew Ukleja, MD, AGAF, CNSP, Assistant Professor, Department of Gastroenterology, Cleveland Clinic Florida, 2950 Cleveland Clinic Blvd, Weston, FL 33331, United States. uklejaa@ccf.org
Telephone: +1-954-6595646 Fax: +1-954-6595647
Received: December 30, 2013
Revised: March 1, 2014
Accepted: April 5, 2014
Published online: July 28, 2014
Core Tip

Core tip: The field of gastroenterology does not currently have standardized treatment guidelines for eosinophilic esophagitis. Current data on the safety of dilations in patients with eosinophilic esophagitis (EoE) are conflicting and lack information on factors that influence whether or not a patient will require dilation. This study revealed that higher peak eos/hpf counts appear to influence whether or not an EoE patient will require dilation during the course of their treatment. However, complications appear to occur independently of the histologic features. Esophageal dilation appears to be a safe procedure in EoE patients, carrying a low complication rate.